Kantos Master Nexthaler

Beclometasone dipropionate / Formoterol fumarate, the active ingredient in Kantos Master Nexthaler, is an inhaled corticosteroid/long‑acting β2‑agonist combination presented as a dry powder inhaler for inhalation use. It is indicated for maintenance treatment of asthma and chronic obstructive pulmonary disease in adult and adolescent patients.

GNH USA supplies Kantos Master Nexthaler as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide from its EU‑originated manufacturing sources. The company ensures quality and regulatory compliance through rigorous quality assurance processes.

Kantos Master Nexthaler, a combined inhaled corticosteroid and long‑acting β2‑agonist, is used in the management of obstructive airway diseases. - Asthma: reduces airway inflammation and provides bronchodilation for improved symptom control. - COPD: delivers maintenance bronchodilation and anti‑inflammatory effects to lessen exacerbations. - Severe persistent asthma: enhances lung function and decreases reliance on rescue inhalers.

The inhaled combination may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Oral thrush (candidiasis) - Hoarseness or voice change - Cough or throat irritation - Headache Serious or Rare Side Effects: - Paradoxical bronchospasm - Adrenal suppression - Severe allergic reaction (anaphylaxis)

When prescribing Kantos Master Nexthaler, consider the following precautions. - Assess infection risk: monitor for oral candidiasis and treat promptly. - Evaluate cardiovascular status: use cautiously in patients with arrhythmias or ischemic heart disease. - Avoid abrupt discontinuation: taper the dose if long‑term high‑dose therapy is required. - Limit concurrent inhaled steroids: monitor for systemic corticosteroid effects. - Pregnancy and lactation: consult a healthcare professional as safety data are limited. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Kantos Master Nexthaler may interact with other medicines; review the following. Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator response and precipitate bronchospasm. - MAO inhibitors: can increase risk of hypertensive episodes with LABA component. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise systemic corticosteroid exposure. Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate hypokalemia caused by β2‑agonist activity. - Theophylline: additive stimulant effects on the cardiovascular system. - Other inhaled corticosteroids: increase total glucocorticoid load, raising risk of systemic effects.